MiRNAs As Non-invasive Biomarkers for Lung Cancer Diagnosis

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2014 Jun 19

PMID 24941344

Citations 29

Authors

Paola Ulivi

Wainer Zoli

Affiliations

Soon will be listed here.

Abstract

Lung cancer is a leading cause of cancer death and late diagnosis is one of the most important reasons for the high mortality rate. Circulating microRNAs (miRNAs) represent stable and reproducible markers for numerous solid tumors, including lung cancer, and have been hypothesized as non-invasive diagnostic markers. Serum, plasma or whole peripheral blood can be used as starting material, and several methodological approaches have been proposed to evaluate miRNA expression. The present review provides an in depth summary of current knowledge on circulating miRNAs in different types of biological samples used as diagnostic markers of lung cancer. We also evaluate the diagnostic accuracy of each miRNA or group of miRNAs in relation to the different housekeeping miRNAs used. Finally, the limitations and potential of miRNA analysis are discussed.

Citing Articles

Epigenetic modifications in early stage lung cancer: pathogenesis, biomarkers, and early diagnosis.

Bi L, Wang X, Li J, Li W, Wang Z MedComm (2020). 2025; 6(3):e70080.

PMID: 39991629 PMC: 11843169. DOI: 10.1002/mco2.70080.

The application of nanoparticles in delivering small RNAs for cancer therapy.

Zhou T, Qiu J, Han X, Zhang X, Wang P, Xie S Discov Oncol. 2024; 15(1):500.

PMID: 39331172 PMC: 11436575. DOI: 10.1007/s12672-024-01341-1.

The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer.

He T, Wu Z, Xia P, Wang W, Sun H, Yu L Front Oncol. 2022; 12:1047019.

PMID: 36531072 PMC: 9748614. DOI: 10.3389/fonc.2022.1047019.

The role of muscle-specific MicroRNAs in patients with chronic obstructive pulmonary disease and skeletal muscle dysfunction.

Zhao H, Li P, Wang J Front Physiol. 2022; 13:954364.

PMID: 36338492 PMC: 9633658. DOI: 10.3389/fphys.2022.954364.

Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment.

Fariha A, Hami I, Tonmoy M, Akter S, Al Reza H, Bahadur N Heliyon. 2022; 8(10):e11081.

PMID: 36303933 PMC: 9593298. DOI: 10.1016/j.heliyon.2022.e11081.

References

Mozzoni P, Banda I, Goldoni M, Corradi M, Tiseo M, Acampa O . Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer. Biomarkers. 2013; 18(8):679-86. DOI: 10.3109/1354750X.2013.845610. View

Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F . A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7):2257-61. PMC: 1413718. DOI: 10.1073/pnas.0510565103. View

Xu J, Wu C, Che X, Wang L, Yu D, Zhang T . Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog. 2011; 50(2):136-42. DOI: 10.1002/mc.20712. View

Roth C, Stuckrath I, Pantel K, Izbicki J, Tachezy M, Schwarzenbach H . Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors. PLoS One. 2012; 7(6):e38248. PMC: 3366929. DOI: 10.1371/journal.pone.0038248. View

Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N . Plasma miR-208 as a biomarker of myocardial injury. Clin Chem. 2009; 55(11):1944-9. DOI: 10.1373/clinchem.2009.125310. View

Bianchi F, Nicassio F, Marzi M, Belloni E, DallOlio V, Bernard L . A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med. 2011; 3(8):495-503. PMC: 3377091. DOI: 10.1002/emmm.201100154. View

Garzon R, Marcucci G, Croce C . Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010; 9(10):775-89. PMC: 3904431. DOI: 10.1038/nrd3179. View

S S Quintans J, Antoniolli A, Onofre F, Onofre A . Detection of lung cancer using multiple genetic markers--a systematic review. Diagn Cytopathol. 2013; 41(9):834-42. DOI: 10.1002/dc.22978. View

Jeong H, Kim E, Lee J, Lee J, Yoo H, Kim J . Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Mol Med Rep. 2011; 4(2):383-7. DOI: 10.3892/mmr.2011.430. View

10.

Zen K, Zhang C . Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev. 2012; 32(2):326-48. DOI: 10.1002/med.20215. View

11.

Iorio M, Ferracin M, Liu C, Veronese A, Spizzo R, Sabbioni S . MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65(16):7065-70. DOI: 10.1158/0008-5472.CAN-05-1783. View

12.

Park N, Zhou H, Elashoff D, Henson B, Kastratovic D, Abemayor E . Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009; 15(17):5473-7. PMC: 2752355. DOI: 10.1158/1078-0432.CCR-09-0736. View

13.

Leidinger P, Keller A, Borries A, Huwer H, Rohling M, Huebers J . Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer. 2011; 74(1):41-7. DOI: 10.1016/j.lungcan.2011.02.003. View

14.

Li N, Ma J, Guarnera M, Fang H, Cai L, Jiang F . Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer. J Cancer Res Clin Oncol. 2013; 140(1):145-150. PMC: 3898839. DOI: 10.1007/s00432-013-1555-5. View

15.

Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, Rom W . microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol. 2013; 8(9):1156-62. PMC: 4123222. DOI: 10.1097/JTO.0b013e318299ac32. View

16.

Showe M, Vachani A, Kossenkov A, Yousef M, Nichols C, Nikonova E . Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res. 2009; 69(24):9202-10. PMC: 2798582. DOI: 10.1158/0008-5472.CAN-09-1378. View

17.

Collino F, Deregibus M, Bruno S, Sterpone L, Aghemo G, Viltono L . Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One. 2010; 5(7):e11803. PMC: 2910725. DOI: 10.1371/journal.pone.0011803. View

18.

Fleischhacker M, Dietrich D, Liebenberg V, Field J, Schmidt B . The role of DNA methylation as biomarkers in the clinical management of lung cancer. Expert Rev Respir Med. 2013; 7(4):363-83. DOI: 10.1586/17476348.2013.814397. View

19.

Shen J, Liu Z, Todd N, Zhang H, Liao J, Yu L . Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer. 2011; 11:374. PMC: 3175224. DOI: 10.1186/1471-2407-11-374. View

20.

Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N . Serum microRNAs are promising novel biomarkers. PLoS One. 2008; 3(9):e3148. PMC: 2519789. DOI: 10.1371/journal.pone.0003148. View